|
|
Allergy and Asthma Therapeutics Markets: U.S.Published by: Frost & Sullivan Published: May. 1, 1997 - 546 Pages Table of ContentsExecutive Summary Introduction to the Industry Strategic Analysis and Forecasts of the Total U.S. Allergy and Asthma Therapeutics Market Strategic Analysis and Forecasts of the U.S. Antihistamines Market Strategic Analysis and Forecasts of the U.S. Corticosteroids Market Strategic Analysis and Forecasts of the U.S. Immunotherapeutics Market Strategic Analysis and Forecasts of the U.S. Bronchodilators Market Strategic Analysis and Forecasts of the U.S. Mast-Cell Stabilizers Market Strategies for Success Profiles of Strategically Targeted Companies Database of Key Industry Participants AbstractThis report on the U.S. markets for allergy and asthma therapeutics includes allergy symptomatic treatment (single-entity antihistamines, antihistamine and decongestant combinations, single-entity topical corticosteroids, nasal corticosteroids, and ophthalmic anti-allergy agents), anti-asthma treatment (sympathomimetics, single-entity xanthines, anticholinergics, inhaled corticosteroids, mast cell stabilizers, and systemic corticosteroids), allergy diagnostic and immunotherapy (allergy diagnostics, and immunotherapy), and anti-asthma medical devices (nebulizers and peak-flow monitors).Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||